EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

In‐vivo pilot study to assess a new plant‐based cosmetic formulation containing Ziziphus joazeiro bark extract and Apium graveolens seed extract for the improvement of dandruff while enhancing scalp microbiome balance and barrier function in subjects with oily to dry sensitive scalps

Phil Barry, Jun Ning Teo, Jing Jing Guo, Peter Engels iD, Katharina Droste, Annika Kathrin Michaelis, Werner Voss

International Journal of Cosmetic Science · 2026

DOI: 10.1111/ics.70011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cosmetic Science, 2026. Verfasst von Phil Barry und 6 weiteren Autor:innen. Beteiligte Einrichtung: Alliance Pharma Ltd, Chippenham, Wiltshire, UK. Hauptthemen laut MEDLINE: Plant Extracts, Microbiota, Dandruff, Plant Bark. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Alliance Pharma Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Dandruff is one of the most common dermatological conditions, which occurs in about 50% of human individuals confined only to the scalp. Microbiome studies indicate a bacterial and fungal microbiota shift compared to a healthy scalp. While antifungal treatments are effective in improving clinical signs and symptoms of scalp dandruff, maintaining a healthy scalp microbiome balance is also crucial for long‐term scalp health. The objective of this study was to investigate whether a novel plant‐based formula containing Ziziphus joazeiro bark extract and Apium graveolens seed extract is capable of reducing mild‐to‐moderate dandruff symptoms and restoring the scalp skin barrier function and its impact on the microbiota balance after a 4‐week application period.

Methods

An open‐label, single‐centre study was performed including 40 subjects with mild‐to‐moderate dandruff with either oily or dry sensitive scalp. Subjects were treated for 4 weeks with a novel plant‐based shampoo to demonstrate the efficacy in reduction of dandruff (scaling) and redness and stabilization of trans‐epidermal water loss (TEWL). Dermatological measurements were performed as well as a scalp microbiome analysis of 20 subjects with a focus on alpha and beta diversity and abundance of core microbiota. The analysis was performed on swab samples taken prior to and 28 days after application of the product of interest.

Results

Clinical data revealed that the new plant‐based shampoo was well tolerated. TEWL analysis showed a highly significant improvement (−18.60%, p = 0.00035). With respect to redness (−22.8%, p = 0.00127) and dandruff reduction (scaling, −29.23%, p = 0.000001), a significant improvement in the analysed parameters was also determined. Microbiome analysis revealed no significant changes in alpha or beta diversity, suggesting that the product has no negative impact on microbial diversity or affecting the overall structure of microbial communities within individuals. Interestingly, fungal species seem not to be involved in dandruff development within the analysed cohort. The key finding was a significant median increase in the Cutibacterium / Staphylococcus ratio (+19.57%).

Conclusion

The study indicates that mild‐to‐moderate dandruff symptoms can successfully be reduced with the plant‐based shampoo by restoring the bacterial scalp microbiome balance, suggesting a ‘microbiome‐friendly’ formulation tolerated excellently for oily scalp and sensitive scalp.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plant ExtractsMicrobiotaDandruffPlant BarkScalpSeedsZiziphusCosmeticsHumansPilot ProjectsFemaleAdultMaleMiddle AgedYoung Adult

Stichwörter der Autor:innen

Nizoraldandruffhair treatmentmicrobiologyscalp microbiotaskin barrier

Substanzen

Plant ExtractsCosmetics

Autor:innen und Institutionen

  • Alliance Pharma Ltd, Chippenham, Wiltshire, UK.
  • Alliance Pharma Ltd, Singapore.
  • Gartenstrasse 25, D-51429, Bergisch Gladbach, Germany.
  • SanderStrothmann GmbH, Gerorgsmarienhuette, Germany.
  • Dermatest GmbH, Muenster, Germany.

ORCID-Profile: Peter Engels

Förderung

  • Alliance Pharma Ltd

Zitieren

APA

Barry, P., Teo, J. N., Guo, J. J., Engels, P., Droste, K., Michaelis, A. K., & Voss, W. (2026). In‐vivo pilot study to assess a new plant‐based cosmetic formulation containing Ziziphus joazeiro bark extract and Apium graveolens seed extract for the improvement of dandruff while enhancing scalp microbiome balance and barrier function in subjects with oily to dry sensitive scalps. International Journal of Cosmetic Science. https://doi.org/10.1111/ics.70011

Vancouver

Barry P, Teo JN, Guo JJ, Engels P, Droste K, Michaelis AK, et al. In‐vivo pilot study to assess a new plant‐based cosmetic formulation containing Ziziphus joazeiro bark extract and Apium graveolens seed extract for the improvement of dandruff while enhancing scalp microbiome balance and barrier function in subjects with oily to dry sensitive scalps. International Journal of Cosmetic Science. 2026. doi:10.1111/ics.70011

BibTeX
@article{Barry2026,
  author = {Barry, Phil and Teo, Jun Ning and Guo, Jing Jing and Engels, Peter and Droste, Katharina and Michaelis, Annika Kathrin and Voss, Werner},
  title = {In‐vivo pilot study to assess a new plant‐based cosmetic formulation containing Ziziphus joazeiro bark extract and Apium graveolens seed extract for the improvement of dandruff while enhancing scalp microbiome balance and barrier function in subjects with oily to dry sensitive scalps},
  journal = {International Journal of Cosmetic Science},
  year = {2026},
  doi = {10.1111/ics.70011}
}
Kostenlos starten →